Growth Metrics

Erasca (ERAS) Operating Expenses (2020 - 2026)

Erasca posted quarterly Operating Expenses of $187.9 million for Q1 2026, up 427.4% year-on-year from $35.6 million in Q1 2025, and up 476.34% on a QoQ basis from $32.6 million in Q4 2025.

Erasca (ERAS) has 7 years of Operating Expenses data on file, last reported at $187.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Operating Expenses rose 427.4% year-over-year to $187.9 million; the trailing twelve-month figure through Mar 2026 stood at $293.2 million (up 66.24% YoY), and the FY2025 full-year result was $140.9 million, down 21.54% from the prior year.
  • Operating Expenses for Q1 2026 stood at $187.9 million, up from $32.6 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $187.9 million in Q1 2026 and bottomed at $32.6 million in Q4 2025.
  • The 5-year median for Operating Expenses is $36.5 million (2022), against an average of $52.8 million.
  • The widest annual swing landed in 2023, when Operating Expenses sank 75.47%; it then surged 427.4% in 2026.
  • A 5-year view of Operating Expenses shows it stood at $138.1 million in 2022, then tumbled by 75.47% to $33.9 million in 2023, then grew by 5.43% to $35.7 million in 2024, then fell by 8.7% to $32.6 million in 2025, then jumped by 476.34% to $187.9 million in 2026.
  • The last three Operating Expenses figures came in at $187.9 million (Q1 2026), $32.6 million (Q4 2025), and $34.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 2.97 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 4.33 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -138.30 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 15.76 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.85 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -3.82 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 2.96 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 898.54 Mn
10 Erasca 4.21 Bn 3.97 Bn - 187.91 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 187.91 Mn
Dec 31, 2025 32.60 Mn
Sep 30, 2025 34.55 Mn
Jun 30, 2025 38.13 Mn
Mar 31, 2025 35.63 Mn
Dec 31, 2024 35.71 Mn
Sep 30, 2024 37.24 Mn
Jun 30, 2024 67.78 Mn
Mar 31, 2024 38.85 Mn
Dec 31, 2023 33.87 Mn
Sep 30, 2023 34.66 Mn
Jun 30, 2023 35.97 Mn
Mar 31, 2023 37.03 Mn
Dec 31, 2022 138.08 Mn
Sep 30, 2022 36.96 Mn
Jun 30, 2022 35.91 Mn
Mar 31, 2022 36.51 Mn
Dec 31, 2021 31.05 Mn
Sep 30, 2021 46.04 Mn
Jun 30, 2021 28.18 Mn
Mar 31, 2021 19.61 Mn
Dec 31, 2020 66.97 Mn
Sep 30, 2020 11.16 Mn
Jun 30, 2020 7.28 Mn